Big price increases thread 2

[LifeOfAShowGirl]

Lots of very useful discussions going on on the old thread, so I thought I would continue it!

I’m good until Christmas and like I said to my mum, hopefully I’ll be somewhere close to 12/13 stone. It would be a big effort but hopefully doable. If I reach that point I’ll have a decision to make. I’m just hoping my pens from Oushk get dispatched soon enough and I can relax until after my holiday.

It’s not as simple as just changing over to wegovy. I tried that and it was horrible. I was never off the toilet. Loads more side effects than mj. What a nightmare.

Well yes I’m not surprised she said that, but Oushk is a commercial enterprise isn’t it, it’s not the NHS or a charity. Why would someone need to take three months deciding whether or not to switch to Wegovy? It makes sense for them to shift as much as they can now, just in case demand falls dramatically in September and they’re left with a load of Mounjaro that they need to store and can’t sell. I’m sure Hira is lovely but ultimately she is in business and of course the needs of the business have to come ahead of the needs of individual patients.

Sorry if this has been said, there are so many posts to follow, but Boots have sent round an email saying they are actively reviewing prices and will update soon. They are already very much higher than elsewhere, eg. £219 (without 10% reorder discount) for a 2.5 mg pen, so not sure what will happen! They did mention helping people who needed to transition to other options, so they are clearly expecting a rise big enough to be a dealbreaker for some.

I guess we just have different impressions of what happened yesterday, I watched the first live and you could tell she had been crying all morning and she was very emotional on the live. I think it was just a bad choice from her to try and help in the way she thought was best.

Personally I’m going to take the time because I don’t know what this journey looks like for me now. If the noise about £330 is true for Oushk, fine, I’ll continue with them. But if it’s way, way more than that or it’s going to keep increasing, I’ll take the time to research other drugs.

Sticking to my good diet & exercise regime has gone quite well after a year on MJ got the habits firmly established. I'm 2lbs heavier than I was when I stopped in March & my weight is stable. My concern w Wegovy is that they might also hike prices. Saxenda, liraglutide, is out of patent now so anyone can make it which means no one manufacturer can hold everyone hostage. The test results are not as good as Wegovy or MJ & the injections are daily, which is why it's less used. For me, there is an element of compulsively eating sugary foods & not being able to stop which feels like addiction, so an antiaddiction tablet might help.

Just seen this on LinkedIn.

All to do with Trump. This is going to upset the drugs market massively.

Might be useful for maintenance though, thanks

Many will have to stop the treatment now!

Eli Lilly statement.

https://investor.lilly.com/news-releases/news-release-details/statement-americas-leading-role-biopharmaceutical-innovation?fbclid=IwQ0xDSwML_1RleHRuA2FlbQIxMQABHjt_1FqLbXYV1_ohRFg9pset0ln414bTRbZNTHqlDiTeA43De0riZJhtvd1c_aem_JupFnWFbEV_HgtC2UWwwvg

”This rebalancing may be difficult, but it means the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the US.”

“Medicine prices should reflect their value for patients, health systems, and society. In recent months, we have intensified efforts to align prices across developed countries, especially in Europe. We are continuing to work with certain governments and expect to make any necessary pricing adjustments by September 1, while providing continued access for patients. This includes an agreement with the UK government to increase the list price of Mounjaro, while maintaining access for NHS patients.”

@LifeOfAShowGirl yes it was submitted on the 5th July.

Fingers crossed then!!!

@LifeOfAShowGirl

Whoever thinks the UK price iincreases are enough to reduce US prices by 50% is a fucking idiot. The number of people taking these meds in the USA outnumbers the UK 10 to 1. The maths don't even come close to working.

Plus, what everyone (worldwide) seems to be forgetting when considering the UK to be unfairly freeloading is that we've got the NHS who now has a MJ contract - which means every single taxpayer in the UK is already paying something towards these meds, whether they personally take them or not.

What I DO think is true is that the price increase for private prescriptions is subsidising the rate the NHS has.

It's perfectly possible for a multi-billion dollar outfit to just drop the prices in the states. There's no 'in order' about it, it's a choice.

"“Medicine prices should reflect their value for patients, health systems, and society. "

I could not disagree with this statement more. It's a polite way of saying "we should charge as much as we dare".

Medicine (life saving, improving drugs) should reflect the cost of development, research and manufacture of those medicines.

They’ve raised their private list prices so the cut isn’t as bad in the USA, but it’ll still be massive and tons more people will go on it

Thanks for this info, 🤞🤞🤞 !!

Don’t forget our list price in the UK for 15mg was £122. So that was a huge, huge cut for the American cost. That’s why they’ve increased it.

By that Linkedin posts own numbers, even if every GLP taker in the UK (around a million) was on the 15mg dose, that's about $541m more raised by raising prices.

A 50% cut of estimated USA users (assuming all on 15mg) would result in $5,500m less revenue.

Not even close. I calculate it would be about $53 less per pen in the US, IF all the UK extra money was used to discount the US. Which, we all know, is never going to happen.

But the massive reduction in cost opens it up to many, many more American users. It’s not about recouping their losses.

But the massive reduction in cost opens it up to many, many more American users. It’s not about recouping their losses.

Maybe they'll massively reduce the US price. I don't know. But my point is, it won't be the UK money paying for that reduction. It'll be Elly deciding to take less profit in the hope it wins mmore profit longer term.

I don’t think you’re understanding the background.

Trump has said that all drugs companies have 60 days before the prices of their medications are cut to the lowest list price in the developed world for Eli Lilly and Mounjaro, that was £122 for 15mg in the UK. They’ve raised prices to a point where they predict that they can still make a profit in the UK, while also not taking a horrendous hit in the USA. Meanwhile in the USA, many many more people are going to go on it because of the huge price cut. There’s a lot of speculation online that Trump doesn’t understand the pricing of weight loss jabs entirely, but this isn’t just limited to Mounjaro. It’s all drugs.

Damn. Now I understand why I couldn’t even log in to family Chemist last night while innocently trying to put my usual order in ….

I get that. My point (perhaps not clearly expressed) was towards the viewpoint I've seen that the UK is subsidised by the USA. That's clearly not true.

What this is showing is that Eli could have ALWAYS put the US price point lower because it is not the UK raising prices that is enabling the lower prices in the US. That's just them making sure there isn't a cheaper price elsewhere in the world. They've decided £300 is a price point at which they can still make a shit ton of money globally and keep their shareholders happy (though yesterday the share price tanked - I suppose it will climb again).